The Oncology Institute
TOI
51 hedge funds and large institutions have $219M invested in The Oncology Institute in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 8
7% more capital invested
Capital invested by funds: $206M → $219M (+$13.5M)
2.06% more ownership
Funds ownership: 93.89% → 95.95% (+2.1%)
4% less funds holding
Funds holding: 53 → 51 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14.6M |
| 2 |
OPU
Omni Partners US
Irvine,
California
|
+$6.96M |
| 3 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$6.07M |
| 4 |
6CM
683 Capital Management
New York
|
+$2.82M |
| 5 |
AWG
Alpha Wave Global
New York
|
+$1.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$12.5M |
| 2 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$10.5M |
| 3 |
BPIM
Brant Point Investment Management
New York
|
-$2.56M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.26M |
| 5 |
SRCM
Sage Rock Capital Management
New York
|
-$1.05M |
TOI Hedge Fund Activity: Q3 2021 in Review
51 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute (TOI) for Q3 2021, worth a combined $219M — up 6.6% from $206M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of TOI and 5 opened new positions — a net loss of 2 holders — while 8 trimmed existing stakes and 12 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $14.6M. The largest seller was Park West Asset Management, exiting entirely with an estimated $12.5M sold.
- 51 institutional investors held The Oncology Institute (TOI) as of Q3 2021, down from 53 in Q2 2021.
- Funds reported $219M of The Oncology Institute stock for Q3 2021, up 6.6% quarter-over-quarter.
- 5 funds opened new The Oncology Institute positions in Q3 2021 and 7 closed out, a net change of -2 holders.
- The largest The Oncology Institute buyer in Q3 2021 was Citadel Advisors, an estimated $14.6M added.
- The largest The Oncology Institute seller in Q3 2021 was Park West Asset Management, an estimated $12.5M sold.
Based on aggregated 13F filings for Q3 2021.